Beckenham, United Kingdom

Frederick C Copp


Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • London, EN (1977)
  • Beckenham, Kent, GB (1986 - 1989)
  • Beckenham, GB (1980 - 1991)

Company Filing History:


Years Active: 1977-1991

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Frederick C Copp

Introduction

Frederick C Copp is a notable inventor based in Beckenham, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Copp has made remarkable advancements that have impacted various medical applications.

Latest Patents

Copp's latest patents include innovative compounds such as the 14b-hexahydrodibenzo[c,f]pyrazino-[1,2-a]azepino derivatives. This compound features a general formula where X can be CH₂, O, S, or NR⁴, and Y is defined by a specific formula involving various substituents. Additionally, he has developed a triazine salt, specifically 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate, which boasts high water solubility. This property allows for parenteral administration in a sterile aqueous solution suitable for injection.

Career Highlights

Throughout his career, Frederick C Copp has worked with prominent companies, including Burroughs Wellcome Co. His work has been instrumental in advancing pharmaceutical formulations and drug delivery systems.

Collaborations

Copp has collaborated with notable individuals in the industry, including David Collard and Albert G Caldwell. These partnerships have contributed to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Frederick C Copp's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical treatments and drug formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…